Skip to main content
    C

    Clover Health Investments Corp (CLOV)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NASDAQ

    $4.95
    -0.01 (-0.20%)

    Market Cap: $2.66B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Clover Health Investments Corp (CLOV) Financials: Revenue, Profit and Cash Flow

    Updated Nov 4, 2026. Financial statements from company filings, amounts in US dollars.

    Clover Health Investments reported revenue of $1.92B for the fiscal year ended Dec 31, 2025, up 40.4% from the year before. That year, net income was -$85.55M with a net margin of -4.4%, operating cash flow was -$66.93M and free cash flow was -$68.98M. The quarter ended Sep 30, 2026 had revenue of $759.30M and net income of $6.43M.

    Revenue and Margins

    The operating margin was -4.4% in the fiscal year ended Dec 2025. Over the 7 years to Dec 2025, revenue grew from $281.02M, a compound annual rate of 31.6%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$1.92B+40.4%18.5%-4.4%-4.4%
    Dec 2024$1.37B+9.1%26.6%-3.3%-3.1%
    Dec 2023$1.26B+13.6%20.4%-16.4%-17.0%
    Dec 2022$1.11B-24.7%9.4%-25.9%-30.7%
    Dec 2021$1.47B+101.0%-5.4%-43.4%-40.0%
    Dec 2020$730.65M+156.7%11.3%-12.7%-18.7%
    Dec 2019$284.68M+1.3%4.4%-64.4%-127.8%
    Dec 2018$281.02MN/A100.0%-66.1%-71.9%
    Annual, fiscal years ended Dec 2018 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Revenue$1.92B$1.37B$1.26B$1.11B$1.47B$730.65M$284.68M$281.02M
    Cost of revenue$1.57B$1.01B$1.00B$993.07M$1.55B$590.08M$449.70MN/A
    Gross profit$355.88M$364.80M$255.95M$103.48M-$79.18M$82.81M$12.56M$281.02M
    Operating income-$85.53M-$45.75M-$205.33M-$286.66M-$636.99M-$92.71M-$183.20M-$185.80M
    Net income-$85.55M-$43.01M-$213.36M-$339.57M-$587.76M-$136.39M-$363.74M-$201.93M
    EBITDAN/AN/AN/A-$255.34MN/A$45.74MN/A-$16.13M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$759.30M$743.17M$749.19M$487.71M$496.65M$477.62M$462.33M$336.50M$330.99M$356.26M$346.92M$307.66M
    Gross profitN/AN/A$159.54M$74.21M$73.18M$99.63M$108.89M$93.92M$81.21M$107.91M$81.76M$62.27M
    Operating incomeN/AN/A$27.33M-$49.32M-$24.38M-$10.56M-$1.27M-$21.45M-$8.79M$7.19M-$22.70M-$65.66M
    Net income$6.43M$28.00M$27.33M-$49.32M-$24.38M-$10.58M-$1.27M-$22.09M-$9.15M$7.41M-$19.17M-$70.47M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents of $78.30M were 14.5% of total assets of $541.01M, against total liabilities of $232.31M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Total assets$541.01M$580.74M$570.67M$808.62M$950.80M$267.25M$100.35K$210.60M
    Current assets$307.86M$343.12M$427.97M$625.00M$752.55M$189.78M$67.60M$75.40M
    Cash and equivalents$78.30M$194.54M$116.41M$103.79M$299.97M$92.35M$0$75.40M
    Total liabilities$232.31M$239.60M$284.28M$451.73M$411.49M$432.70M$117.98K$265.42M
    Short-term debtN/AN/A$1.67M$222.03M$74.66M$20.80M$0N/A
    Long-term debtN/AN/AN/AN/A$19.94M$106.41MN/AN/A
    Shareholder equity$308.70M$341.09M$286.39M$356.89M$535.41M-$617.10M-$17.63K-$54.83M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$753.68M$720.33M$697.73M$541.01M$559.66M$574.99M$583.72M$580.74M$653.01M$674.21M$671.77M$570.67M
    Total liabilities$362.81M$344.07M$358.30M$232.31M$218.73M$230.81M$247.64M$239.60M$310.85M$349.32M$379.30M$284.28M
    Cash and equivalents$268.07M$198.84M$173.26M$78.30M$190.06M$188.65M$155.44M$194.54M$287.96M$254.77M$208.25M$116.41M
    Shareholder equity$390.87M$376.26M$339.43M$308.70M$340.93M$344.18M$336.07M$341.14M$342.17M$324.89M$292.47M$286.39M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Operating cash flow-$66.93M$34.84M-$144.66M-$203.93M-$282.33M-$118.50M-$159.88M-$153.28M
    Capital expenditures$2.04M$1.56M$584.00K$4.47M$723.00K$693.00K$23.00K$1.48M
    Free cash flow-$68.98M$33.29M-$145.25M-$208.39M-$283.05M-$119.19M-$159.90M-$154.76M
    Dividends paidN/AN/AN/AN/A$305.00K$957.00KN/AN/A
    Share repurchases$18.30M$1.77M$0$6.36M$232.00K$957.00K$0N/A
    Investing cash flow$4.08M$565.00K$140.01M$95.13M-$435.45M$137.40M-$181.91M$97.53M
    Financing cash flow-$53.38M-$17.36M-$5.07M-$4.96M$925.39M$5.84M$333.98M$74.59M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$70.38M$25.19M$107.89M-$68.15M$12.10M$5.41M-$16.29M-$85.83M$49.99M$44.76M$25.93M-$258.09M
    Capital expenditures$898.00K$682.00K$854.00K$597.00K$692.00K$569.00K$185.00K$315.00K$399.00K$397.00K$445.00K$264.00K
    Free cash flow$69.48M$24.51M$107.04M-$68.75M$11.41M$4.84M-$16.48M-$86.15M$49.59M$44.36M$25.49M-$258.35M
    Last 12 quarters

    Frequently Asked Questions About CLOV

    What is Clover Health Investments' annual revenue?

    Clover Health Investments reported revenue of $1.92B for the fiscal year ended Dec 31, 2025.

    How fast is Clover Health Investments' revenue growing?

    Revenue was up 40.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 20.3%.

    Is Clover Health Investments profitable?

    No. Clover Health Investments reported net income of -$85.55M for the fiscal year ended Dec 31, 2025, with a net margin of -4.4%.

    How much free cash flow does CLOV generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$66.93M minus capital expenditures of $2.04M produced free cash flow of -$68.98M.

    How much debt does Clover Health Investments have?

    The balance sheet dated Dec 31, 2025 reported cash and equivalents of $78.30M.